Artificial Intelligence Predicts Next Session’s Price Change For Kinder Morgan, BeiGene, PT Telekomunikasi

(VIANEWS) – Today, the Innrs artificial intelligence algorithm suggests a high probability of discovering the approximate price for tomorrow of Kinder Morgan KMI, BeiGene BGNE and others.

Via News will regularly fact-check this AI algorithm that aims to consistently predict the next session price and next week’s trend of financial assets.

Innrs provides A.I.-based statistical tools to help investors make decisions. The table below shows the financial assets predicting price, ordered by the highest expected accuracy.

Innrs officials say this tool helps investors make better-informed decisions, supposedly used alongside other relevant financial information and the specific trader strategy.

In the next session, Via News will report the finding on the algorithm precision.

1. Kinder Morgan (KMI)

Shares of Kinder Morgan fell 4.39% in from $18.13 to $17.33 at 18:21 EST on Monday, following the last session’s downward trend. NYSE is rising 0.18% to $15,492.93, following the last session’s downward trend.

Kinder Morgan, Inc. operates as an energy infrastructure company in North America. The company operates through four segments: Natural Gas Pipelines, Products Pipelines, Terminals, and CO2. The Natural Gas Pipelines segment owns and operates interstate and intrastate natural gas pipeline, and underground storage systems; natural gas gathering systems and natural gas processing and treating facilities; natural gas liquids fractionation facilities and transportation systems; and liquefied natural gas gasification, liquefaction, and storage facilities. The Products Pipelines segment owns and operates refined petroleum products, and crude oil and condensate pipelines; and associated product terminals and petroleum pipeline transmix facilities. The Terminals segment owns and/or operates liquids and bulk terminals that stores and handles various commodities, including gasoline, diesel fuel, renewable fuel stock, chemicals, ethanol, metals, and petroleum coke; and owns tankers. The CO2 segment produces, transports, and markets CO2 to recovery and production crude oil from mature oil fields; owns interests in/or operates oil fields and gasoline processing plants; and operates a crude oil pipeline system in West Texas, as well as owns and operates RNG and LNG facilities. It owns and operates approximately 83,000 miles of pipelines and 140 terminals. The company was formerly known as Kinder Morgan Holdco LLC and changed its name to Kinder Morgan, Inc. in February 2011. Kinder Morgan, Inc. was founded in 1936 and is headquartered in Houston, Texas.

Revenue Growth

Year-on-year quarterly revenue growth grew by 3.5%, now sitting on 19.2B for the twelve trailing months.

Moving Average

Kinder Morgan’s value is below its 50-day moving average of $18.21 and under its 200-day moving average of $18.07.

Volatility

Kinder Morgan’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.42%, a negative 0.32%, and a positive 1.03%.

Kinder Morgan’s highest amplitude of average volatility was 0.88% (last week), 0.97% (last month), and 1.03% (last quarter).

More news about Kinder Morgan.

2. BeiGene (BGNE)

Shares of BeiGene slid by a staggering 18.08% in from $265.91 to $217.83 at 18:21 EST on Monday, after five consecutive sessions in a row of losses. NASDAQ is jumping 0.63% to $11,466.98, following the last session’s downward trend.

BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; XGEVA to treat giant cell tumor of bone; BLINCYTO to treat acute lymphoblastic leukemia; KYPROLIS to treat R/R multiple myeloma; SYLVANT to treat idiopathic multicentric castleman disease; QARZIBA to treat neuroblastoma; Pamiparib for the treatment of various solid tumors; and Pobevcy to treat metastatic colorectal cancer, liver cancer, and non-small cell lung cancer (NSCLC). The company's clinical stage drug candidates comprise Zanubrutinib, a BTK inhibitor to treat lymphomas; Tislelizumab, an anti-PD-1 antibody to treat solid and hematological cancers; Lifirafenib and BGB-3245 to treat melanoma, NSCLC, and endometrial cancer; and Sitravatinib, a multi-kinase inhibitor to treat NSCLC, melanoma, and other solid tumors. Its clinical stage drug candidates also include BGB-A333, a PD-L1 inhibitor to treat various solid tumors; Ociperlimab, a TIGIT inhibitor to treat various solid tumors; BGB-11417, a small molecule Bcl-2 inhibitor to treat mature B-cell malignancies; BGB-A445, an OX40 agonist antibody to treat solid tumors; Zanidatamab, a bispecific HER2 inhibitor to treat breast and gastric cancer; BGB-A425, a T-cell immunoglobulin and mucin-domain containing-3 inhibitor to treat various solid tumors; and BGB-15025, a small molecule inhibitor of HPK1. The company has strategic collaborations with Shoreline Biosciences, Inc., Amgen Inc., Novartis AG, and Bristol Myers Squibb company. BeiGene, Ltd. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.

More news about BeiGene.

3. PT Telekomunikasi (TLK)

Shares of PT Telekomunikasi slid 2% in from $26.5 to $25.97 at 18:21 EST on Monday, after five successive sessions in a row of gains. NYSE is jumping 0.18% to $15,492.93, following the last session’s downward trend.

Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk provides telecommunications, informatics, and network services worldwide. The company's Mobile segment offers mobile voice, SMS, and mobile broadband services; and digital services, including financial services, video on demand, music, gaming, IoT, big data analytics, and digital advertising services. Its Consumer segment provides fixed voice and broadband services; and IPTV and related consumer digital services. The company's Enterprise segment offers ICT and digital platform that covers enterprise-grade connectivity services, including satellite, IT services, data center and cloud, and business process outsourcing services, as well as CPE trading and managed, cyber security, financial, big data, digital advertising, e-health, managed ATM, and professional services. Its Wholesale and International Business segment provides wholesale voice, managed, A2P SMS, IP transit and connectivity, data center and cloud, security, and value added and digital services; mobile network operator, mobile virtual network operator, and call center services; and tower and infrastructure services to other licensed operator companies and institutions. The company's Others segment offers digital services, such as digital platform, digital content, and e-commerce; and property management services. The company also provides building management and maintenance services, payment, business management consulting and capital venture, health insurance administration, tourism, directory information, telecommunication construction, and multimedia portal services; acts as a civil consultant and developer; and leases offices. As of December 31, 2020, it had approximately 9.1 million fixed wireline subscribers, including 8.0 million fixed broadband subscribers; and 169.5 million cellular subscribers, including 115.9 million mobile broadband subscribers. The company was founded in 1884 and is headquartered in Bandung, Indonesia.

Volatility

PT Telekomunikasi’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.27%, a negative 0.04%, and a positive 1.15%.

PT Telekomunikasi’s highest amplitude of average volatility was 1.27% (last week), 0.99% (last month), and 1.15% (last quarter).

More news about PT Telekomunikasi.

4. FibroGen (FGEN)

Shares of FibroGen jumped 3.79% in from $21.64 to $22.46 at 18:21 EST on Monday, after four consecutive sessions in a row of losses. NASDAQ is rising 0.63% to $11,466.98, following the last session’s downward trend.

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China for anemia associated with myelodysplastic syndromes. It is also developing Pamrevlumab, a human monoclonal antibody that inhibits the activity of connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, liver fibrosis, and diabetic kidney disease, as well as Phase III trial for the treatment of Duchenne muscular dystrophy. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

Volatility

FibroGen’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.78%, a positive 0.12%, and a positive 2.83%.

FibroGen’s highest amplitude of average volatility was 1.78% (last week), 1.92% (last month), and 2.83% (last quarter).

Moving Average

FibroGen’s value is way above its 50-day moving average of $20.09 and way above its 200-day moving average of $14.75.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is 35.2% and a drop 20.6% for the next.

More news about FibroGen.

5. Coinbase (COIN)

Shares of Coinbase jumped 4.86% in from $56.18 to $58.91 at 18:21 EST on Monday, after two sequential sessions in a row of losses. NASDAQ is rising 0.63% to $11,466.98, following the last session’s downward trend.

Coinbase Global, Inc. provides financial infrastructure and technology for the cryptoeconomy in the United States and internationally. The company offers the primary financial account in the cryptoeconomy for retailers; a marketplace with a pool of liquidity for transacting in crypto assets for institutions; and technology and services that enable ecosystem partners to build crypto-based applications and securely accept crypto assets as payment. Coinbase Global, Inc. was founded in 2012 and is based in Wilmington, Delaware.

Sales Growth

Coinbase’s sales growth for the current quarter is negative 30.6%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 97.7% and a negative 101.2%, respectively.

More news about Coinbase.

6. Aware, Inc. (AWRE)

Shares of Aware, Inc. dropped 4.35% in from $1.68 to $1.61 at 18:21 EST on Monday, after four successive sessions in a row of losses. NASDAQ is jumping 0.63% to $11,466.98, following the last session’s downward trend.

Aware, Inc. provides biometrics software products and solutions in the United States, Brazil, the United Kingdom, and internationally. It offers biometrics software products, including biometric search and matching software development kits (SDKs); biometric enrollment SDKs and application programming interfaces (APIs); and imaging products for medical and advanced imaging applications, such as JPEG2000 product to compress, store, and display images, as well as software maintenance services. The company also provides Knomi mobile biometric authentication framework; AwareABIS, an automated biometric identification system; AFIX suite of products for small-scale law enforcement focused biometric identification; BioSP, a biometric services platform; WebEnroll, a browser-based biometric enrollment and data management solution; AwareID, a software-as-a-service that provides biometric face and voice analysis for liveness-verification, and document validation; and Fortress Identity Biometric Authenticator and Onboarding Authentication Platform, which offers multi-factor authentication through passive and active biometrics for multiple modalities, including voice, fingerprint, face, and behavior to enable online onboarding and identity proofing. In addition, it offers program management and software engineering services, including project planning and management; system and architecture design; software design, development, customization, configuration, and testing; and software integration and installation. The company's software portfolio enables government agencies and commercial entities to enroll, identify, authenticate, and enable using biometrics, such as fingerprints, faces, irises, and voices. The company sells its products through systems integrators, original equipment manufacturers, value added resellers, and partners, as well as directly to end user customers. Aware, Inc. was incorporated in 1986 and is headquartered in Burlington, Massachusetts.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Aware, Inc.’s stock is considered to be overbought (>=80).

More news about Aware, Inc..

7. SmileDirectClub (SDC)

Shares of SmileDirectClub dropped 3.7% in from $0.56 to $0.54 at 18:21 EST on Monday, after five successive sessions in a row of losses. NASDAQ is rising 0.63% to $11,466.98, following the last session’s downward trend.

SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment with a network of approximately 250 licensed orthodontists and general dentists through its teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 16% and 26.3%, respectively.

More news about SmileDirectClub.

8. Moderna (MRNA)

Shares of Moderna slid by a staggering 30.92% in from $201.04 to $138.88 at 18:21 EST on Monday, after five successive sessions in a row of losses. NASDAQ is jumping 0.63% to $11,466.98, following the last session’s downward trend.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Revenue Growth

Year-on-year quarterly revenue growth declined by 32.3%, now sitting on 21.39B for the twelve trailing months.

More news about Moderna.

9. Arcturus Therapeutics (ARCT)

Shares of Arcturus Therapeutics slid by a staggering 26.9% in from $21.92 to $16.02 at 18:21 EST on Monday, after two successive sessions in a row of losses. NASDAQ is rising 0.63% to $11,466.98, following the last session’s downward trend.

Arcturus Therapeutics Holdings Inc. operates as a late-stage clinical mRNA medicines and vaccines company. Its technologies include LUNAR lipid-mediated delivery; STARR mRNA Technology (samRNA); and mRNA drug substance. The company's pipeline of RNA therapeutic and vaccine candidates includes mRNA vaccine programs for SARS-CoV-2 (COVID-19) and Influenza, and other programs to treat ornithine transcarbamylase (OTC) deficiency, and cystic fibrosis with partnered programs, including glycogen storage disease type III and hepatitis B virus. Its RNA therapeutics platforms can be applied in multiple types of nucleic acid medicines, including messenger RNA, small interfering RNA, circular RNA, antisense RNA, self-amplifying RNA, DNA, and gene editing therapeutics. Its technologies are covered by its patent portfolio, including patents and patent applications issued in the U.S., Europe, Japan, China, and other countries. The company was founded in 2013 and is headquartered in San Diego, California.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Arcturus Therapeutics’s stock is considered to be overbought (>=80).

Volatility

Arcturus Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.43%, a negative 1.31%, and a positive 3.31%.

Arcturus Therapeutics’s highest amplitude of average volatility was 3.74% (last week), 3.08% (last month), and 3.31% (last quarter).

More news about Arcturus Therapeutics.

10. Honda (HMC)

Shares of Honda rose 7.61% in from $24.32 to $26.17 at 18:21 EST on Monday, following the last session’s downward trend. NYSE is jumping 0.18% to $15,492.93, following the last session’s downward trend.

Honda Motor Co., Ltd. develops, manufactures, and distributes motorcycles, automobiles, power products, and other products in Japan, North America, Europe, Asia, and internationally. It operates through four segments: Motorcycle Business, Automobile Business, Financial Services Business, and Life Creation and Other Businesses. The Motorcycle Business segment produces motorcycles, including sports, business, and commuter models; and various off-road vehicles, such as all-terrain vehicles and side-by-sides. The Automobile Business segment offers passenger cars, light trucks, and mini vehicles. The Financial Services Business segment provides various financial services, including retail lending and leasing services to customers, as well as wholesale financing services to dealers. The Life Creation and Other Businesses segment manufactures and sells power products, such as general purpose engines, generators, water pumps, lawn mowers, riding mowers, robotic mowers, brush cutters, tillers, snow blowers, outboard marine engines, walking assist devices, and portable battery inverter power sources. This segment also offers HondaJet aircraft. The company also sells spare parts; and provides after-sale services through retail dealers directly, as well as through independent distributors and licensees. Honda Motor Co., Ltd. was founded in 1946 and is headquartered in Tokyo, Japan.

Revenue Growth

Year-on-year quarterly revenue growth grew by 6.9%, now sitting on 14.8T for the twelve trailing months.

Moving Average

Honda’s worth is higher than its 50-day moving average of $23.94 and higher than its 200-day moving average of $24.45.

Volatility

Honda’s last week, last month’s, and last quarter’s current intraday variation average was 0.21%, 0.26%, and 1.03%.

Honda’s highest amplitude of average volatility was 0.63% (last week), 1.10% (last month), and 1.03% (last quarter).

Yearly Top and Bottom Value

Honda’s stock is valued at $26.17 at 18:21 EST, way below its 52-week high of $32.15 and way higher than its 52-week low of $21.44.

More news about Honda.

11. Clean Energy Fuels (CLNE)

Shares of Clean Energy Fuels jumped 4.19% in from $5.49 to $5.72 at 18:21 EST on Monday, following the last session’s downward trend. NASDAQ is rising 0.63% to $11,466.98, following the last session’s downward trend.

Clean Energy Fuels Corp. provides natural gas as an alternative fuel for vehicle fleets and related fueling solutions, primarily in the United States and Canada. It supplies renewable natural gas (RNG), compressed natural gas (CNG), and liquefied natural gas (LNG) for medium and heavy-duty vehicles; and offers operation and maintenance services for public and private vehicle fleet customer stations. The company also designs, builds, operates, and maintains fueling stations; and sells and services compressors and other equipment that are used in RNG production and fueling stations. In addition, it transports and sells CNG, RNG, and LNG through virtual natural gas pipelines and interconnects; sells U.S. federal, state, and local government credits, such as RNG as a vehicle fuel, including Renewable Identification Numbers and Low Carbon Fuel Standards credits; and obtains federal, state, and local credits, grants, and incentives. Further, the company focuses on developing, owning, and operating dairy and other livestock waste RNG projects. It serves heavy-duty trucking, airports, refuse, public transit, industrial, and institutional energy users, as well as government fleets. As of December 31, 2021, the company served approximately 1,000 fleet customers operating approximately 48,000 vehicles; and owned, operated, or supplied approximately 548 fueling stations in 42 states in the United States and 25 fueling stations in Canada. Clean Energy Fuels Corp. was incorporated in 2001 and is headquartered in Newport Beach, California.

Moving Average

Clean Energy Fuels’s value is higher than its 50-day moving average of $5.60 and under its 200-day moving average of $5.90.

More news about Clean Energy Fuels.

12. American Airlines (AAL)

Shares of American Airlines slid 1.85% in from $15.97 to $15.67 at 18:21 EST on Monday, following the last session’s downward trend. NASDAQ is rising 0.63% to $11,466.98, following the last session’s downward trend.

American Airlines Group Inc., through its subsidiaries, operates as a network air carrier. The company provides scheduled air transportation services for passengers and cargo through its hubs in Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C., as well as through partner gateways in London, Madrid, Seattle/Tacoma, Sydney, and Tokyo. As of December 31, 2021, it operated a mainline fleet of 865 aircraft. The company was formerly known as AMR Corporation and changed its name to American Airlines Group Inc. in December 2013. American Airlines Group Inc. was founded in 1930 and is headquartered in Fort Worth, Texas.

Sales Growth

American Airlines’s sales growth is 37.7% for the ongoing quarter and 3.5% for the next.

Moving Average

American Airlines’s value is above its 50-day moving average of $15.19 and higher than its 200-day moving average of $14.46.

Revenue Growth

Year-on-year quarterly revenue growth grew by 39.9%, now sitting on 48.97B for the twelve trailing months.

Volatility

American Airlines’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.28%, a negative 0.29%, and a positive 2.09%.

American Airlines’s highest amplitude of average volatility was 2.27% (last week), 1.58% (last month), and 2.09% (last quarter).

More news about American Airlines.

13. Xerox Corporation (XRX)

Shares of Xerox Corporation rose 1.18% in from $16.12 to $16.31 at 18:21 EST on Monday, after two consecutive sessions in a row of losses. NYSE is rising 0.18% to $15,492.93, following the last session’s downward trend.

Xerox Holdings Corporation, a workplace technology company, designs, develops, and sells document management systems and solutions in the United States, Europe, Canada, and internationally. It offers workplace solutions, including desktop monochrome, and color and multifunction printers; digital printing presses and light production devices, and solutions; and digital services that leverage workflow automation, personalization and communication software, content management solutions, and digitization services. The company also provides graphic communications and production solutions; and IT services, end user computing devices, network infrastructure, communications technology, and a range of managed IT solutions, such as technology product support, professional engineering, and commercial robotic process automation. In addition, it provides FreeFlow a portfolio of software solutions for the automation and integration to the processing of print job comprises file preparation, final production, and electronic publishing; XMPie, a personalization and communication software that support the needs of omni-channel communications customers; DocuShare, a content management platform to capture, store, and share paper and digital content; and CareAR, an enterprise augmented reality business. Further, the company sells paper products and wide-format systems. The company sells its products and services directly to its customers through its direct sales force, as well as through independent agents, dealers, value-added resellers, systems integrators, and e-commerce marketplaces. Xerox Holdings Corporation was founded in 1906 and is headquartered in Norwalk, Connecticut.

Volatility

Xerox Corporation’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.76%, a negative 0.18%, and a positive 1.87%.

Xerox Corporation’s highest amplitude of average volatility was 1.93% (last week), 1.45% (last month), and 1.87% (last quarter).

Sales Growth

Xerox Corporation’s sales growth is negative 0.1% for the current quarter and 1.3% for the next.

Revenue Growth

Year-on-year quarterly revenue growth declined by 2.6%, now sitting on 6.95B for the twelve trailing months.

More news about Xerox Corporation.

14. Amerco (UHAL)

Shares of Amerco fell 1.39% in from $65.84 to $64.92 at 18:21 EST on Monday, after two successive sessions in a row of gains. NASDAQ is jumping 0.63% to $11,466.98, following the last session’s downward trend.

U-Haul Holding Company operates as a do-it-yourself moving and storage operator for household and commercial goods in the United States and Canada. The company's Moving and Storage segment rents trucks, trailers, portable moving and storage units, specialty rental items, and self-storage spaces primarily to the household movers; and sells moving supplies, towing accessories, and propane. It also provides uhaul.com, an online marketplace that connects consumers to independent Moving Help service providers and independent self-storage affiliates; auto transport and tow dolly options to transport vehicles; and specialty boxes for dishes, computers, flat screen television, and sensitive electronic equipment, as well as tapes, security locks, and packing supplies. This segment rents its products and services through a network of approximately 2,100 company operated retail moving stores and 21,100 independent U-Haul dealers. As of March 31, 2022, it had a rental fleet of approximately 186,000 trucks, 128,000 trailers, and 46,000 towing devices; and 1,844 self-storage locations with approximately 876,000 rentable storage units. The company's Property and Casualty Insurance segment offers loss adjusting and claims handling services. It also provides moving and storage protection packages, such as Safemove and Safetow packages, which offer moving and towing customers with a damage waiver, cargo protection, and medical and life insurance coverage; Safestor that protects storage customers from loss on their goods in storage; Safestor Mobile, which protects customers stored belongings; and Safemove Plus, which provides rental customers with a layer of primary liability protection. The company's Life Insurance segment provides life and health insurance products primarily to the senior market through the direct writing and reinsuring of life insurance, medicare supplement, and annuity policies. The company was formerly known as AMERCO. U-Haul Holding Company was founded in 1945 and is based in Reno, Nevada.

Volatility

Amerco’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.07%, a negative 0.22%, and a positive 1.84%.

Amerco’s highest amplitude of average volatility was 1.20% (last week), 1.74% (last month), and 1.84% (last quarter).

Yearly Top and Bottom Value

Amerco’s stock is valued at $64.92 at 18:21 EST, below its 52-week high of $70.57 and way above its 52-week low of $44.79.

More news about Amerco.

15. Merrimack Pharmaceuticals (MACK)

Shares of Merrimack Pharmaceuticals fell 0.18% in from $11.42 to $11.40 at 18:21 EST on Monday, after two sequential sessions in a row of losses. NASDAQ is rising 0.63% to $11,466.98, following the last session’s downward trend.

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Merrimack Pharmaceuticals’s stock is considered to be oversold (<=20).

Volatility

Merrimack Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.05%, a negative 0.03%, and a positive 1.31%.

Merrimack Pharmaceuticals’s highest amplitude of average volatility was 1.23% (last week), 0.93% (last month), and 1.31% (last quarter).

More news about Merrimack Pharmaceuticals.

16. Zai Lab (ZLAB)

Shares of Zai Lab fell by a staggering 19.02% in from $44.22 to $35.81 at 18:21 EST on Monday, following the last session’s downward trend. NASDAQ is jumping 0.63% to $11,466.98, following the last session’s downward trend.

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; and Qinlock to treat gastrointestinal stromal tumors. It also develops Odronextamab to treat follicular lymphoma, diffuse large B-cell lymphoma, and other B-celllymphomas; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Margetuximab for the treatment of breast and gastroesophageal cancers; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, pancreatic cancer, and other solid tumors; and Bemarituzumab to treat gastric and gastroesophageal junction cancer. In addition, the company develops CLN-081 for the treatment of patients with EGFR exon 20 insertion NSCLC; Elzovantinib, an orally bioavailable multi-targeted kinase inhibitor; Tebotelimab, a tetravalent IgG4 monoclonal antibody; Retifanlimab that inhibits interactions between PD-1 and its ligands; ZL-2309, an orally active, selective, and ATP-competitive cell division cycle 7 (CDC7) kinase inhibitor; ZL-1201, a humanized IgG4 monoclonal antibody; Efgartigimod to reduce disease-causing immunoglobulin G antibodies; ZL-1102, a human nanobody targeting interleukin- 17A; KarXT for the treatment of psychiatric and neurological conditions; ZL-2313, an investigational inhibitor of triple-mutant EGFR harboring; ZL-2314, an investigational inhibitor of double-mutant EGFR harboring; and Sulbactam/durlobactam for the treatment of serious infections caused by Acinetobacter. Zai Lab Limited was incorporated in 2013 and is headquartered in Shanghai, China.

Volatility

Zai Lab’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.27%, a negative 1.25%, and a positive 4.14%.

Zai Lab’s highest amplitude of average volatility was 1.46% (last week), 2.66% (last month), and 4.14% (last quarter).

Moving Average

Zai Lab’s value is under its 50-day moving average of $38.53 and under its 200-day moving average of $36.70.

Yearly Top and Bottom Value

Zai Lab’s stock is valued at $35.81 at 18:21 EST, way below its 52-week high of $56.06 and way higher than its 52-week low of $20.98.

More news about Zai Lab.